March Biosciences
Latest round
- Series A
Last raised
- Oct 2024
Total raised
- $22M
Investors
- 11
About March Biosciences
Based in Texas, US, and founded in 2021 by Sarah Hein (CEO), Max Mamonkin, and Malcolm Brenner, March Biosciences, Inc. operates as a biotechnology company that develops drugs for patients suffering from hematological cancers and offers treatment to patients with leukemias and lymphomas. In October 2024, March Biosciences, Inc. March Biosciences is a clinical-stage cell therapy firm comprised of cell therapy experts and medication developers. The company is working on a pipeline of new cell treatments for cancer treatment, with an emphasis on T-cell cancers. In addition, the comapny leads the development and commercialization of cell treatments that aim to alter the lives of cancer patients, driven by a vision to reinvent cancer therapy.'s Phase 2 clinical development CAR-T therapy, MB-105, optimize manufacturing processes, and advance additional pipeline products.
Who invested in March Biosciences
11 investors across 1 round
See all investors in March Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 7, 2024
Amount
$22M
Investors
Questions about March Biosciences
Who invested in March Biosciences?
March Biosciences has 11 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has March Biosciences raised?
March Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did March Biosciences last raise money?
March Biosciences's most recent round on record is a Series A, in Oct 2024.
What does March Biosciences do?
Based in Texas, US, and founded in 2021 by Sarah Hein (CEO), Max Mamonkin, and Malcolm Brenner, March Biosciences, Inc.
Where is March Biosciences headquartered?
March Biosciences is headquartered in Houston, US.
Which VCs invest in companies like March Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at March Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like March Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.